AGP Picks
View all

Daily news on health and wellness in Nauru

Provided by AGP

Wellness Daily Nauru: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Daily Nauru.

Press releases published on May 19, 2026

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
RenovoRx to Present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20th
Prana IV Therapy Highlights Emerging Research on Magnesium’s Role in Stress and Neurological Function
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
リゼン・ファーマ、アルツハイマー病による軽度認知障害を対象としたRP902の、第2相治験の開始を発表
Risen Pharma, 알츠하이머병 관련 경도인지장애 치료제 RP902 임상 2상 개시 발표
Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy
NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment
AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026
Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium
ITM to Announce Dosimetry Data from the Phase 3 COMPETE Trial at SNMMI 2026 and Host Satellite Symposium
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
Seven Peer-Reviewed Studies Expand Research Into Vielight’s Light-Based Neurotechnology
Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC
BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks

Share us

on your social networks:

Sign up for:

Wellness Daily Nauru

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.